Stockreport

This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop [Yahoo! Finance]

TG Therapeutics, Inc.  (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF On February 17, 2026, ACT Capital Management disclosed a new position in TG Therapeutics (NASDAQ:TGTX) , acquiring 268,875 shares worth $8,015,164. What happened Ac [Read more]